Coherus Biosciences Inc (NASDAQ:CHRS) Climbs 113.96% In 2024; Is It Attractive Enough At $1.52?
In recent trading session, Coherus Biosciences Inc (NASDAQ:CHRS) saw 0.8 million shares changing hands at last check today with its beta currently measuring 0.78. Company’s